Amgen’s Lyophilized Peptibody Patent Upheld by Madras High Court
Madras High Court backs Amgen on lyophilized peptibody formulations, rejecting Section 3(d), 3(e) and inventive step objections. Grant directed, with claims narrowed to supported sequences.